Latécoère S.A. (LON:0IXT)
0.0163
+0.0013 (8.67%)
At close: Dec 30, 2025
Latécoère Revenue
Latécoère had revenue of 374.61M EUR in the half year ending June 30, 2025, with 23.31% growth. This brings the company's revenue in the last twelve months to 731.26M, up 8.97% year-over-year. In the year 2024, Latécoère had annual revenue of 708.73M with 13.80% growth.
Revenue (ttm)
731.26M EUR
Revenue Growth
+8.97%
P/S Ratio
0.28
Revenue / Employee
148.30K EUR
Employees
4,931
Market Cap
177.31M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 708.73M | 85.97M | 13.80% |
| Dec 31, 2023 | 622.77M | 155.96M | 33.41% |
| Dec 31, 2022 | 466.81M | 133.73M | 40.15% |
| Dec 31, 2021 | 333.07M | -80.66M | -19.49% |
| Dec 31, 2020 | 413.73M | -299.90M | -42.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |